Donor History Deferral: Current Research and New Considerations in Donor Selection
Dr. Brian Custer discusses U.S. studies focused on new approaches for donor selection and individual risk questioning strategies, and he reviews areas requiring further investigation, including ART and PrEP use.
The HIV Pandemic: Evolution of Knowledge, Diagnostics, and Genomic Diversity
Approximately 34 million people in the world are living with HIV/AIDS. Dr. John Hackett discusses the evolution of technologies for HIV surveillance and implications for future pandemics.
The Use of Antiretroviral Therapies by Blood Donors and Risk Mitigation Strategies
Marion Vermeulen shares studies performed at the South African National Blood Service regarding donors presenting with HIV and ART and mitigation strategies.
THE VIRUS HUNTERS
Abbott scientists working to identify, catalog, track and test mutating strains of HIV, hepatitis, and more, are members of Abbott’s Global Surveillance Program and new virus discovery efforts. The Surveillance Program is a one-of-a-kind collection of HIV and hepatitis virus strains from around the world, including more than 60,000 samples collected over 20 years from 40 countries on six continents.
THE EVOLUTION OF HIV
HIV (human immunodeficiency virus) is not a static infectious agent but a continually evolving virus. To stay one step ahead of HIV, scientists study how the virus is evolving over time.